Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,620.27 -63.71 -2.37%
FTSE 100 6,213.39 -135.43 -2.13%
DAX 8,006.25 -190.83 -2.33%
Ticker Volume Price Price Delta
Nikkei 13,014.60 -230.64 -1.74%
Hang Seng 20,382.90 -604.02 -2.88%
S&P/ASX 200 4,758.39 -102.99 -2.12%
  • Fund Type: SICAV
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Credit Suisse SICAV Lux Equity Biotechnology

+ Add to Watchlist

CLBIEHE:LX

166.81 EUR 2.13 1.29%

As of 00:59:30 ET on 06/18/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Credit Suisse SICAV Lux Equity Biotechnology (CLBIEHE)

Year To Date: +24.76% 3-Month: +10.91% 3-Year: +25.09% 52-Week Range: 124.19 - 177.73
1-Month: -3.44% 1-Year: +35.70% 5-Year: +13.68% Beta vs NBI: 1.02

Mutual Fund Chart for CLBIEHE

No chart data available.
  • CLBIEHE:LX 166.81
  • 1M
  • 1Y
Interactive CLBIEHE Chart

Previous Close

Fund Profile & Information for CLBIEHE

Credit Suisse SICAV (Lux) Equity Biotechnology is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in a portfolio of equity securities of biotechnology companies worldwide.

Inception Date: 02-27-2006 Telephone: -
Managers: IRENE B PUTTNER
Web Site: www.credit-suisse.com

Fundamentals for CLBIEHE

NAV (on 2013-06-18) 166.81
Assets (M) (on 2013-06-18) 162.22
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for CLBIEHE

No dividends reported

Fees & Expenses for CLBIEHE

Front Load -
Back Load -
Current Mgmt Fee 2.00
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CLBIEHE

Filing Date: 04/29/2013
Name Position Value % of Total
Gilead Sciences Inc 260,484 13,308,128 8.018%
Celgene Corp 101,638 12,041,054 7.255%
Biogen Idec Inc 49,745 11,123,479 6.702%
Vertex Pharmaceuticals Inc 127,000 9,947,910 5.994%
Amgen Inc 79,973 8,530,720 5.140%
Regeneron Pharmaceuticals Inc 38,000 8,188,240 4.933%
BioMarin Pharmaceutical Inc 125,444 8,081,102 4.869%
Onyx Pharmaceuticals Inc 82,000 7,859,700 4.736%
Alexion Pharmaceuticals Inc 74,752 7,375,032 4.443%
Incyte Corp Ltd 245,000 5,394,900 3.250%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil